Title
untitled
By
null
Description
1163 Kirk D. Willis (kwillis@godwinpappas.com) heads the personal injury litigation departtmen of Godwin Pappas Langley Ronquillo, LLP, in Dallas. ANTICIPATING A VIOXX DEFENSE STRATEGY: WILL CORPORATE HONESTY BE ENOUGH? Kirk D. Willis i. introduction The pharmaceutical megacompany Merck voluntarily withdrew its popular arthritis medication, Vioxx, from the market on September 30, 2004.1 This decision was “based on new, three-year data from a prospective, randomizzed placebo-controlled clinical...

Advertisement